February 22-25, 2021

We are attending the 4th Annual Gene Therapy For Rare Disorders Conference. This year’s conference will focus on overcoming challenges faced when delivering gene therapies to market. Contact us to discuss how Advarra’s Institutional Biosafety Committee (IBC) Services provides comprehensive review and oversight of clinical trials involving recombinant DNA, synthetic nucleic acid molecules, genetic engineering, and gene therapy research.

View the Conference Website




Add to Calendar

Back to Events